This grant supports small research projects by new, diverse investigators in health-related fields to broaden participation and facilitate research independence.
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health - https://www.nih.gov
Due Dates: January 7, 2028 (Next due date)
Funding Amounts: Up to $125,000 in direct costs per year for small research projects, typically short-term (R21 mechanism)
Summary: Supports small health-related research projects by new investigators from diverse and underrepresented backgrounds to broaden participation and facilitate transition to research independence.
Key Information: New investigators must have less than $125,000 in direct costs of combined research funding (excluding NIH training and career awards). Clinical trial optional.
This funding opportunity supports new investigators from diverse backgrounds, including those from groups nationally underrepresented in biomedical research, to conduct small-scale research projects aligned with the scientific mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and participating NIH Institutes and Centers.
The grant mechanism is an R21, which is designed for exploratory and developmental research projects that can be completed in a short period with limited resources. It supports various project types such as pilot and feasibility studies, secondary analysis of existing data, small self-contained research projects, development of research methodology, and new research technology.
The program aims to broaden participation in health-related research and facilitate the transition of new investigators to research independence. Eligible applicants are those who, at the time of award, have had less than $125,000 in direct costs of combined research funding (excluding NIH training and career awards).
This opportunity allows for clinical trials but does not require them.